Developing better and safer medicines for children with leukaemia
Screening for novel drug combinations in childhood B-cell acute lymphoblastic leukaemia
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Screening for novel drug combinations in childhood B-cell acute lymphoblastic leukaemia
Identification of new drug targets to improve treatment options and reduce treatment-related toxicity for children diagnosed with aggressive B-cell non-Hodgkin lymphoma (B-NHL)
In vitro evaluation of the potential of glucose restriction as an adjuvant therapy for paediatric brain tumours
Brain distribution models to select polymer-delivered drugs for the treatment of childhood brain cancers
Defining the cellular origins of neonatal and paediatric brain tumours